Literature DB >> 12975292

Neuroradiological study of patients with amyotrophic lateral sclerosis and parkinsonism-dementia complex on the Kii peninsula of Japan.

Yasumasa Kokubo1, Shigeki Kuzuhara.   

Abstract

BACKGROUND: The Kii peninsula of Japan, together with Guam and West New Guinea, has one of the highest incidences of amyotrophic lateral sclerosis (ALS) and parkinsonism-dementia complex (PDC) in the world.
OBJECTIVE: To perform neuroimaging studies on patients with ALS and PDC on the Kii peninsula.
METHODS: Results of computed tomography, magnetic resonance imaging, and single-photon emission computed tomography were studied in 4 patients with ALS and in 10 patients with PDC from the Hohara village on the Kii peninsula of Japan.
RESULTS: In patients with PDC, there was mild to severe atrophy of the frontal and temporal lobes on computed tomography and magnetic resonance imaging and a marked decrease in cerebral blood flow on single-photon emission computed tomography. In contrast, in patients with ALS, there was a decrease in cerebral blood flow of the frontal and temporal lobes, although the patients did not show signs of clinical dementia or obvious brain atrophy on computed tomography or magnetic resonance imaging.
CONCLUSION: The finding of an obvious decrease in cerebral blood flow of the frontal and temporal lobes in patients with PDC and ALS with or without cerebral atrophy supports the concept that the 2 conditions are different manifestations of a single frontotemporal tauopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12975292     DOI: 10.1001/archneur.60.9.1257

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

Review 1.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

2.  Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex.

Authors:  Yui Nakayama; Satoru Morimoto; Misao Yoneda; Shigeki Kuzuhara; Yasumasa Kokubo
Journal:  J Neurodegener Dis       Date:  2013-03-27

3.  Neuropsychological study of amyotrophic lateral sclerosis and parkinsonism-dementia complex in Kii peninsula, Japan.

Authors:  Akihiro Shindo; Yukito Ueda; Shigeki Kuzuhara; Yasumasa Kokubo
Journal:  BMC Neurol       Date:  2014-07-21       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.